• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.42% Nasdaq Up0.25%

    Alexza Pharmaceuticals Inc. (ALXA)

    -NasdaqCM
    0.54 Down 0.02(2.73%) 2:04PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
    Total Revenue 673   1,773   1,875   705  
    Cost of Revenue7,175  3,675  4,132  6,147  
    Gross Profit (6,502) (1,902) (2,257) (5,442)
    Operating Expenses
    Research Development1,668  2,463  3,761  3,824  
    Selling General and Administrative1,813  3,232  3,423  3,737  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (9,983) (7,597) (9,441) (13,003)
    Income from Continuing Operations
    Total Other Income/Expenses Net9,015  4,128  (811)14,828  
    Earnings Before Interest And Taxes(968)(3,469)(10,252)1,825  
    Interest Expense2,050  1,969  2,198  2,229  
    Income Before Tax(3,018)(5,438)(12,450)(404)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(3,018)(5,438)(12,450)(404)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (3,018) (5,438) (12,450) (404)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (3,018) (5,438) (12,450) (404)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.